Is Putting the Care Back into Healthcare the Answer?

Two recent news articles highlight the fractured nature of our healthcare delivery system. The first article describes how a radioactive isotope (Molybdenum-99 or “moly-99”) that is vital for imaging the bones and the heart is no longer manufactured in the US. We currently rely on sources as far away as South Africa and Australia to supply it. But now there is an ambitious plan to establish production of moly-99 in the cornfields of Wisconsin. A similar story has emerged with the shortage of intravenous saline (salt) solutions needed in the treatment of the current flu epidemic. The main source has been Puerto Rico, which suffered serious damage from Hurricane Maria and is no longer able to export its goods.

Top Five Trends in Myeloma News for 2018

As the new year begins, important developments that will impact patients have been in the news, ranging from molecular testing to new therapies for myeloma. The depth and scope of these reports reflect what I think are five key trends for 2018 and beyond.

ASH 2017: Separating Hype from Hope About CAR T-Cell Therapy

At the 2017 Annual Meeting of the American Society of Hematology (ASH) in Atlanta (December 9th -12th), 981 abstracts dealt with myeloma-related topics. Among all of these— some of which were discussed on the IMWG Conference Series broadcast on Monday, December 11th, and which I will discuss in more detail during the ASH Highlights Teleconference on January 11th-- the “big buzz” was about the CAR T-cell (chimeric antigen receptors) clinical trial results.

iStopMM— A Year Later

The iStopMM (Screens, Treat, or Prevent Multiple Myeloma) project was launched on November 15, 2016, with strong support from the Black Swan Research Initiative®. Two weeks ago, IMF President & CEO Susie Durie, Senior Vice President of Clinical Education & Research Initiatives Lisa Paik, and I visited the University of Iceland to celebrate the one-year anniversary with Principal Investigator Dr. Sigurdur Kristinsson and his 16-member iStopMM team. I am thrilled to report that the results to date are beyond everyone’s expectations.

11th Annual IMF Comedy Celebration Fuels Myeloma Research

On Saturday, November 4, IMF president Susie Novis Durie and I will have the great pleasure once again of welcoming our guests to the 11th Annual Comedy Celebration benefiting the Peter Boyle Research Fund. 

Pages